Sarah Prichard

Sarah Prichard

Director/Board Member at GOODFELLOW INC.

Net worth: 3 918 $ as of 2026-10-30

52 year
Commercial Services
Health Services
Health Technology

Profile

Sarah Prichard is Vice Chairman at Centre universitaire de santé McGill, Independent Director at Goodfellow, Inc. since 2022, and Managing Director & Director at Buro Happold Ltd. Former roles include Director at Kane Biotech, Inc. from 2020 to 2023, Independent Director at Kane Biotech, Inc. from 2014 to 2017, Director-Peritoneal Dialysis at Royal Victoria Hospital, Vice President-Medical Affairs, R&D at Baxter Healthcare Corp.
from 2005 to 2015, and President of The Canadian Society of Nephrology.
Education includes a doctorate from Queen's University.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-30 500 ( 0.01% ) 3 918 $ 2026-10-30

Sarah Prichard active positions

CompaniesPositionStart
GOODFELLOW INC. Director/Board Member 2022-06-06
Director/Board Member -
Director/Board Member 2018-12-19

Former positions of Sarah Prichard

CompaniesPositionEnd
KANE BIOTECH INC. Director/Board Member 2023-02-28
KANE BIOTECH INC. Director/Board Member 2017-08-16
Corporate Officer/Principal 2014-12-31
Corporate Officer/Principal -
President -
See the detail of Sarah Prichard's experience

Education of Sarah Prichard

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

73

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Distribution Services

Commercial Services

Consumer Services

Health Services

Industrial Services

Commercial Services

Health Services

  1. Stock Market
  2. Insiders
  3. Sarah Prichard